9th CAR-TCR Summit
Evvnt Promotion / evvnt
Archivo
17.09.2024 - 20.09.2024 Hynes Convention Center, 900 Boylston Street, 02115 Boston, Massachusetts, USA
Time: 8:00 AM - 5:00 PM
Temas de la conferencia
The commercial success of cell therapies is continuing to grow! With a recent TIL approval, a shift to earlier line CAR-T treatment, and further approvals set for this year, 2024 will be pivotal to demonstrate the clinical benefit of cell therapies and advance breakthroughs in solid tumors and autoimmunity.
The commercial success of cell therapies is continuing to grow! With a recent TIL approval, a shift to earlier line CAR-T treatment, and further approvals set for this year, 2024 will be pivotal to demonstrate the clinical benefit of cell therapies and advance breakthroughs in solid tumors and autoimmunity.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/2431289-3?pid=4832
Speakers: Carl June, Professor in Immunotherapy, Director, Center for Cellular Immunotherapies, University of Pennsylvania, and more
Brochure: https://go.evvnt.com/2431289-3?pid=4832
Speakers: Carl June, Professor in Immunotherapy, Director, Center for Cellular Immunotherapies, University of Pennsylvania, and more
Información e inscripción:
https://go.evvnt.com/2431289-2?pid=4832
Ms. Ellie Saunders
Medicina General
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
